In a later study involving a canine melanoma model, it was also shown that IFN-β-transduced adipose tissue-derived MSCs can be used as carriers of anti-tumor prodrugs, in this case, cisplatin, which improved therapeutic efficacy [19]. The gene discussed is IFNB1; the disease is melanoma.